Cargando…
suPAR as a prognostic biomarker in sepsis
Sepsis is the clinical syndrome derived from the host response to an infection and severe sepsis is the leading cause of death in critically ill patients. Several biomarkers have been tested for use in diagnosis and prognostication in patients with sepsis. Soluble urokinase-type plasminogen activato...
Autores principales: | Donadello, Katia, Scolletta, Sabino, Covajes, Cecilia, Vincent, Jean-Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275545/ https://www.ncbi.nlm.nih.gov/pubmed/22221662 http://dx.doi.org/10.1186/1741-7015-10-2 |
Ejemplares similares
-
SuPAR - A future prognostic biomarker in emergency medicine
por: Østervig, Rebecca M, et al.
Publicado: (2015) -
Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients
por: Nasr El-Din, Asmaa, et al.
Publicado: (2021) -
suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014) -
The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis
por: Gustafsson, Anna, et al.
Publicado: (2012) -
suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009)